Assenagon Asset Management S.A. - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 186 filers reported holding ANI PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
Assenagon Asset Management S.A. ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5,792,124
+433.8%
99,761
+201.8%
0.02%
+500.0%
Q3 2021$1,085,000
-30.6%
33,058
-25.9%
0.00%
-40.0%
Q2 2021$1,564,000
-31.7%
44,617
-29.6%
0.01%
-44.4%
Q1 2021$2,291,000
+48.7%
63,395
+19.5%
0.01%
+28.6%
Q4 2020$1,541,000
-20.0%
53,063
-22.3%
0.01%
-36.4%
Q3 2020$1,926,000
-58.3%
68,257
-52.2%
0.01%
-63.3%
Q2 2020$4,617,000142,7580.03%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
AIGH Capital Management LLC 272,801$15,838,8267.50%
Global Alpha Capital Management Ltd. 525,528$30,512,1563.06%
Rubric Capital Management LP 847,011$49,177,4591.84%
Ranger Investment Management 426,848$24,782,7951.64%
Parkman Healthcare Partners LLC 111,802$6,491,2241.19%
MARATHON CAPITAL MANAGEMENT 71,670$4,161,1601.05%
Mesirow Financial Investment Management, Inc. 3,862$224,2280.98%
Deep Track Capital, LP 400,000$23,224,0000.90%
1492 Capital Management LLC 18,178$1,055,4150.68%
Phocas Financial Corp. 75,213$4,367,0000.64%
View complete list of ANI PHARMACEUTICALS INC shareholders